ArticleOncogene2020

Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA.

Zhanzhan Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.